- Article
LPA3: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites
- K. Helivier Solís,
- M. Teresa Romero-Ávila,
- Ruth Rincón-Heredia,
- Juan Carlos Martínez-Morales and
- J. Adolfo García-Sáinz
Background: Lysophosphatidic acid (LPA) receptor 3 (LPA3) is involved in many physiological and pathophysiological actions of this bioactive lipid, particularly in cancer. The actions of LPA and oleoyl-methoxy glycerophosphothionate (OMPT) were compa...

